White House suggests COVID-19 vaccines effective against ‘lambda’ variant

Published



The White House issued a vote of confidence Tuesday that the COVID-19 vaccines are effective against a new virus variant that has caused concern among health experts.

At issue is the so-called “lambda variant,” which the World Health Organization has called a “variant of interest” because it has mutated in a way that could make it more easily passed among humans and may not be nixed by the “neutralizing antibodies” inside the body that the vaccines produce.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.